
I explain how the words caregiver and incurable shaped my wife’s cancer journey and why I believe more hopeful language better reflects our experience.

I explain how the words caregiver and incurable shaped my wife’s cancer journey and why I believe more hopeful language better reflects our experience.

Cindy and Katie share how finding a friend who understood the caregiving journey made the experience less isolating and helped them navigate loss and hope.

Although most patients with localized kidney cancer have high cancer-specific survival, surveys show a gap between doctor and patient perceptions of cure.

CURE recently sat down with an expert to discuss crucial information for patients with gastrointestinal stromal tumors, or GISTs.

A stamp on my Christmas cards stirred deep memories and reminded me that small actions can make a meaningful impact in the fight against breast cancer.

Among young patients, clinical trial results have shown that Pedmark is associated with a reduction in chemotherapy-induced ear damage.

An expert explained what patients newly diagnosed with gastrointestinal stromal tumors need to know.

Feeling like others have it worse can dismiss the real challenges of follicular lymphoma and leave patients without the support they need.

Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.

Only 5% to 10% of breast cancers are caused by inherited gene mutations like BRCA1 or BRCA2. I do not carry one. But my family history was enough.

I love flowers, and I especially love the Japanese tradition of ikebana. In Japanese culture, ikebana is the art of flower arrangement.

Optimism, treatment momentum and communication gaps drive late systemic therapy, increasing hospitalization and intensive care use for patients with cancer.

The FDA approved Armlupeg as a biosimilar to Neulasta to reduce infection risk in people receiving chemotherapy and those exposed to radiation.


Meta: Stage 1 essential thrombocythemia is a chronic blood disorder with high platelets, manageable through monitoring, medication, lifestyle and care.

Newly diagnosed with stage 3 papillary thyroid cancer? Get the facts on treatment options and side effects to guide the conversation with your physician.

Breaking down what patients need to know about penile cancer, from diagnosis to treatment.

This guide explains diagnosis, staging, molecular testing and treatment options for non-small cell lung cancer to help patients prepare informed questions.

CURE sat down with Dr. Daniel J. Boffa to discuss the current treatment landscape of lung cancer care in recognition of Lung Cancer Awareness Month.

Dr. Daniel J. Boffa discusses advancements in lung cancer care, including the role of minimally invasive surgical techniques and new systemic therapies.

CURE discussed the regional anesthesia technique known as PEC I and II blocks with breast surgeon Dr. Christopher M. McGreevy.

Dr. Lanyi Nora Chen, sat down for a live interview with CURE, in which, she shares her advice for newly diagnosed patients with lung cancer.

Hearing the words “you have cancer” while carrying a baby felt like my whole world stopped.

As we’re about to celebrate Thanksgiving 2025, I’d like to honor someone for whom I’m grateful – my son, Thomas.

Triple-negative breast cancer often needs chemotherapy, surgery, radiation or immunotherapy, and early diagnosis can support strong outcomes.

Bernadette’s strength and optimism lifted me through my own cancer journey and reminded me how much one person’s compassion can change how I move through each day.

Dr. Li-Shiun Chen sat down with CURE to discuss study findings that overturn long-held assumptions about the impact of smoking cessation in cancer care.

Research is underway for an experimental treatment for patients with succinate dehydrogenase deficient gastrointestinal stromal tumors.

After more than 30 years since she was first diagnosed with a myeloproliferative neoplasm, Nona Baker is hopeful for the future thanks to current clinical trial landscape.

Stage 1 polycythemia vera is manageable with monitoring, phlebotomy, medication and lifestyle changes, allowing patients to live healthy, normal lives.